EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England

Gema Requena iD, Alexandrosz Czira iD, Victoria Banks iD, Robert Wood iD, Theo Tritton, Catherine M Castillo iD, Jie Yeap, Rosie Wild iD, Chris Compton iD, Kieran J Rothnie iD, Felix Herth iD, Jennifer K Quint iD und 1 weitere

International Journal of Chronic Obstructive Pulmonary Disease · 2023

DOI: 10.2147/copd.s411437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2023. Verfasst von Gema Requena und 12 weiteren Autor:innen. Beteiligte Einrichtung: GSK, R&D Global Medical, Brentford, Middlesex, UK. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHumansAdultTiotropium BromideBronchodilator AgentsRetrospective StudiesForced Expiratory VolumeTreatment OutcomeAdministration, InhalationBenzyl AlcoholsChlorobenzenesQuinuclidinesDrug PrescriptionsDrug CombinationsBenzoxazines

Stichwörter der Autor:innen

COPD treatmentLABA/LAMAprimary care settingrescue medicationtreatment escalation

Substanzen

Tiotropium BromideBronchodilator AgentsBenzyl AlcoholsChlorobenzenesQuinuclidinesDrug CombinationsvilanterololodaterolBenzoxazinesGSK573719

Autor:innen und Institutionen

  • GSK, R&D Global Medical, Brentford, Middlesex, UK.
  • Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.
  • Department of Pulmonology and Respiratory Care Medicine, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany.
  • Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany.
  • National Heart and Lung Institute, Imperial College London, London, UK.
  • Value Evidence and Outcomes, GSK, Collegeville, PA, USA.

ORCID-Profile: Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Catherine M Castillo, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix Herth, Jennifer K Quint, Afisi S Ismaila

Zitieren

APA

Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C. M., Yeap, J., Wild, R., Compton, C., Rothnie, K. J., Herth, F., Quint, J. K., & Ismaila, A. S. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s411437

Vancouver

Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, et al. Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. International Journal of Chronic Obstructive Pulmonary Disease. 2023. doi:10.2147/copd.s411437

BibTeX
@article{Requena2023,
  author = {Requena, Gema and Czira, Alexandrosz and Banks, Victoria and Wood, Robert and Tritton, Theo and Castillo, Catherine M and Yeap, Jie and Wild, Rosie and Compton, Chris and Rothnie, Kieran J and Herth, Felix and Quint, Jennifer K and Ismaila, Afisi S},
  title = {Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2023},
  doi = {10.2147/copd.s411437}
}
Kostenlos starten →